Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 09-2000 | 06-2000 | |
| Cash Flows From Operating Activities | |||
| Net Income | -492 | N/A | -20,523 |
| Depreciation Amortization | 3 | N/A | -20 |
| Accounts receivable | 23 | N/A | 18 |
| Accounts payable and accrued liabilities | -43 | N/A | -11 |
| Other Working Capital | -8 | N/A | -18 |
| Other Operating Activity | 325 | 0 | 18,687 |
| Operating Cash Flow | $-193 | $N/A | $-1,867 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | 131 | N/A | 127 |
| PPE Investments | N/A | N/A | -1 |
| Other Investing Activity | 0 | 0 | -182 |
| Investing Cash Flow | $131 | $N/A | $-57 |
| Cash Flows From Financing Activities | |||
| Common Stock Repurchased | -17 | N/A | N/A |
| Financing Cash Flow | $-17 | $N/A | $N/A |
| Beginning Cash Position | 489 | N/A | 2,276 |
| End Cash Position | 410 | N/A | 353 |
| Net Cash Flow | $-79 | $N/A | $-1,924 |
| Free Cash Flow | |||
| Operating Cash Flow | -193 | N/A | -1,867 |
| Capital Expenditure | N/A | N/A | -1 |
| Free Cash Flow | -193 | 0 | -1,868 |